# MacroGenics, Inc. (MGNX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MGNX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 153.07M | $ -76.40M | $ -84.94M | N/A | $ 55.59M |
| 2024 | $ 155.92M | $ -70.39M | $ -75.76M | $ 37.46M | $ 116.06M |
| 2023 | $ 63.52M | $ -9.79M | $ -86.47M | $ 33.97M | $ 152.61M |
| 2022 | $ 169.26M | $ -133.56M | $ -101.19M | $ 34.83M | $ 142.01M |
| 2021 | $ 92.06M | $ -240.24M | $ -178.33M | $ 25.47M | $ 239.62M |
| 2020 | $ 125.75M | $ -165.28M | $ -150.07M | $ 29.25M | $ 295.88M |
| 2019 | $ 80.88M | $ -195.95M | $ -178.85M | $ 30.57M | $ 230.63M |
| 2018 | $ 79.40M | $ -226.44M | $ -235.33M | $ 0 | $ 242.88M |
| 2017 | $ 212.50M | $ -26.44M | $ -20.20M | $ 300.0K | $ 299.24M |
| 2016 | $ 126.41M | $ -80.52M | $ -75.75M | $ 1.90M | $ 268.75M |
| 2015 | $ 141.60M | $ -28.28M | $ -32.09M | $ 4.70M | $ 313.34M |
| 2014 | $ 66.78M | $ -54.14M | $ -51.34M | $ 8.00M | $ 121.29M |
| 2013 | $ 80.72M | $ -371.0K | $ -24.37M | $ 9.40M | $ 78.91M |
| 2012 | $ 35.94M | $ 715.7K | $ 15.42M | $ 0 | $ -8.24M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | 3.62 |
| Current Ratio | 5.10 |

## Other views

- [Metrics](https://sponda.capital/en/MGNX.md)
- [Charts](https://sponda.capital/en/MGNX/charts.md)
- [Compare](https://sponda.capital/en/MGNX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.